Research Article
Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS
Table 1
Sociodemographic and medical characteristics ().
| | Sociodemographics | (%) | (SD) |
| | Age | | 54.35 (9.18) | | Education | | | | ā<College degree | 22 (27) | | | āCollege degree | 19 (23) | | | āGraduate/professional training | 40 (50) | | | Race | | | | āCaucasian | 62 (77) | | | āNon-Caucasian | 19 (23) | | | Marital status | | | | āMarried/partner | 50 (62) | | | āSingle/widow/divorced | 31 (38) | | | Annual household income | | | | ā<$50,000 | 14 (17) | | | ā$50,000ā100,000 | 10 (12) | | | ā>$100,000 | 45 (56) | | | āRefused/missing | 12 (15) | |
| | Treatments received | | |
| | Surgery | | | | āLumpectomy | 48 (59) | | | āUnilateral mastectomy | 17 (21) | | | āBilateral mastectomy | 16 (20) | | | Chemotherapy | | | | āYes | 24 (30) | | | āNo | 57 (70) | | | Radiation | | | | āYes | 24 (30) | | | āNo | 57 (70) | | | Tamoxifen | | | | āYes | 47 (58) | | | āNo | 34 (42) | | | Aromatase inhibitors | | | | āYes | 32 (40) | | | āNo | 48 (59) | | | āDo not know | 1 (1) | | | Recurrence Score Treatment | | | | āLow-hormonal therapy | 19 (23) | | | āIntermediate-hormonal therapy | 38 (47) | | | āIntermediate-chemohormonal therapy | 13 (16) | | | āHigh-chemohormonal therapy | 11 (14) | |
| | Psychosocial and quality of life variables | | |
| | Decision style | | | | āPassive | 12 (15) | | | āShared | 29 (36) | | | āActive | 40 (49) | | | Cancer-related distress (IES) | | 19.06 (17.51) | | Decisional conflict | | 1.69 (.51) | | Worry about recurrence | | 1.65 (.83) | | Quality of life (FACT-B) | | 111.75 (18.85) |
|
|
